Table 2. HER2 and MHC class I expressions in tumour cell lines.
| HER2 (MFI) | Class I (MFI) | |
|---|---|---|
| TE4 (ESCC cell line) | 687.0 | 43.4 |
| SK-BR-3 (breast cancer cell line) | 1570.2 | 49.4 |
| BT474 (breast cancer cell line) | 557.6 | 16.0 |
| TE1 (ESCC cell line) | 78.0 | 137.3 |
| TE3 (ESCC cell line) | 28.2 | 312.5 |
| KYSE30 (ESCC cell line) | 67.7 | 98.3 |
| KYSE50 (ESCC cell line) | 65.8 | 67.0 |
| ESTDAB049 (melanoma cell line) | 55.7 | 202.4 |
| HTB122 (breast cancer cell line) | 18.2 | 214.0 |
| PC-9 (lung cancer cell line) | 52.0 | 210.1 |
| KATOIII (gastric cancer cell line) | 114.8 | 313.8 |
Abbreviations: ESCC=oesophageal squamous cell carcinoma; HER2=human epidermal growth factor receptor 2; MFI=mean fluorescence intensity; MHC=major histocompatibility complex.